Ignite Creation Date:
2024-05-05 @ 6:38 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00510471
Status:
TERMINATED
Last Update Posted:
2008-03-18
First Post:
2007-07-31
Brief Title:
Personalized Active Immunotherapy Vaccine Therapy and Sargramostim Given After Standard of Care Treatment With Rituximab and Chemotherapy for Initial Treatment With Lymphoma
Sponsor:
Genitope Corporation
Organization:
Genitope Corporation
Organization Data
Organization:
Genitope Corporation
Class:
INDUSTRY
Study ID:
2007-12
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Genitope Corporation
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None